CDH5 and lung cancer: We observed that exon 19 deletion mutation was associated with upregulation of CDH5 in vitro and in vivo and higher angiogenic ability in the lung cancer cells studied, and the results support the finding that exon 19 deletion and exon 21 L858R mutation have distinct features.